APA (7th ed.) Citation

A, W., G, P., V, V., Y, S., CM, C., SF, V., . . . MA, C. (2026). CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance. Cell reports. Medicine, 7(1), 102565. https://doi.org/10.1016/j.xcrm.2025.102565

Chicago Style (17th ed.) Citation

A, Watterson, et al. "CRISPR Screens in the Context of Immune Selection Identify CHD1 and MAP3K7 as Mediators of Cancer Immunotherapy Resistance." Cell Reports. Medicine 7, no. 1 (2026): 102565. https://doi.org/10.1016/j.xcrm.2025.102565.

MLA (9th ed.) Citation

A, Watterson, et al. "CRISPR Screens in the Context of Immune Selection Identify CHD1 and MAP3K7 as Mediators of Cancer Immunotherapy Resistance." Cell Reports. Medicine, vol. 7, no. 1, 2026, p. 102565, https://doi.org/10.1016/j.xcrm.2025.102565.